Thermovision USA Announces Successful Pilot Clinical Study for TVBIO E-100 Breast Thermal Screening System
California, USA, August 31st, 2019 – Thermovision USA, Inc., is pleased to announce that we have successfully completed the Pilot clinical study for TVBIO E-100 Breast Thermal Screening System. The initial assessment of trial results (Sensitivity, Specificity, PPV and NPV) are exceeding our expectations.
Thermovision Biotek Selected as Finalist of InnoVex Startup Pitch Contest 2019
Taipei, Taiwan, May 31st, 2019 – Thermovision Biotek, Inc., the partner company of Thermovision USA, was selected as one of the 10 finalists from Taiwan, South Korea, and Hong Kong. Out of the 143 startups from 25 countries and regions that joined, 31 continued to the semifinal stage, only 10 finalists were selected in the of InnoVex Startup Pitch Contest 2019.
For more information, please visit InnoVex Startup Pitch Contest 2019
Thermovision USA Initiated First-in-Human (FIH) Clinical Study for TVBIO E-100 Breast Thermal Scanning System
California, USA, December 19th, 2018 – Thermovision USA, Inc., is pleased to announce that our First-in-Human clinical study has received approval from Taiwan FDA and the IRB of the Mackay Memorial Medical Hospital. We have started enrolling study subjects. Look forward to the study result of the First-in-Human clinical study.